Navigation Links
Vacuum device increase breasts

Scientists from Georgia have found that, although a vacuum device promoted as a breast-enhancer does increase a woman's cup size, few women may have the time and commitment to use the product. The device, known as the BRAVA system, requires women to wear two plastic domes over their breasts for 10 hours a day for 10 weeks straight.// The domes are connected to a battery operated, computerized vacuum device. Skipping even a day adds a week to the treatment.

However, the device does seem to be a viable alternative to surgery for women who want bigger breasts, according to Dr. Richard J. Greco, of the Georgia Institute for Plastic Surgery in Savannah. It is only appropriate for women who are a B cup or smaller and are willing to commit to the price and time required, he said.

Previous studies conducted by the inventors of BRAVA suggested that the device could lead to tissue growth not just temporary swelling resulting in long-term breast enhancement. Greco, a member of the American Society of Plastic Surgeons' Device and Technology Committee, attempted to verify those results in an independent study.

While many women expressed interest in the device, only eight women ended up in the study.Some women couldn't commit to the time involved, others had breasts that were too large or chests that were too narrow. Some felt the system was not worth the relatively small gain (one cup size) made in breast size.

According to Greco, a few patients dropped out because we could not make a definite statement as to whether or not this tissue growth stimulation would increase their likelihood of breast cancer in the future. The report says, of the original eight, two dropped out "because of the inconvenience the device created in their lives. Three of the six women who completed the study experienced an increase in breast size that was equal to one bra cup or more. The remaining three women experienced roughly half as much breast tissue growth, study findings indicate.

The "amount of enhancement is relative to (the woman's) size," Greco said. However, the increased breast size remains evident up to 15 months later, according to previous reports. Greco's study did not include long-term follow-up data.

The device is "relatively inconvenient, is heavy, and induces a fair amount of skin irritation along the silicone border/skin interface," Greco writes. "Yet the motivation to have larger breasts seems to overcome this in the correctly chosen individual." The system is also known to cause initial swelling that goes down as the treatment continues, Greco said.

And many of the women experienced technical difficulties with malfunctioning equipment and needed 15 to 30 minutes on a biweekly basis with customer service to help them through the process. The system can be worn during sleep but an alarm will sound if the user inadvertently rolls over the cord, Greco said. This can result in sleep deprivation, a reason one woman cited when she dropped out of the study. The other woman dropped out because of the time commitment required, the researcher said.

Although reviewed by the US Food and Drug Administration (FDA), BRAVA is not regulated by the agency. The ideal candidate for BRAVA would be an individual who does not have a full time job, or someone who begins to use the device immediately after work and is able to sleep in it, Greco said.

Those who obtain the roughly $2,000 device from an authorized physician and are not satisfied with the results or with the inconvenience, however, will not be able to obtain a refund, according to the researcher. "Understand that you're trading off the risks of surgery with the inconvenience of having to wear" the BRAVA device, Greco said.


'"/>




Related medicine news :

1. DVT Treatment Vacuums Away Blood Clots – Prevents Disabilit
2. Alerts for safety of heart device
3. FDA approves new device to treat womens bleeding disorder
4. A new hearing device improves hearing
5. New device for detecting artery blockages
6. New device for discerning Osteoarthritis
7. Screening device for ovarian cancer
8. Innovative device aids in advanced heart failure
9. Latest device for identifying Melanomas
10. Useful device makes spinal surgery safer
11. New device aids esophagal cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their ... Eyeglasses . , Millions of individuals in the United States and Canada wear eyeglasses. ... way to both correct vision and make a fashion statement. Even celebrities use glasses ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: